Hing C Wong

Chief Executive Officer

Hing C Wong (Chief Executive Officer) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in HCW Biologics Inc. (HCWB). Across 1 priced purchase filing, the average 21-session return was -66.4% from execution and -57.6% from disclosure (delay-adjusted; derived). The largest single filing was $160K of HCWB (113,879 sh × $1.41, as filed), executed May 22.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

-66.4%

avg across 1 priced filings

Delay-adjustediThe same average, entered at disclosure dates

-57.6%

same 1 filings, from disclosure

Filings, ttm

1 buys · 0 sells

Median delay

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$160K

shares × price, as filed

Last traded

May 22

Filed May 27

Open performance→

Volume by month

Buys $2.6M Sells $0

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names

HCWB

HCW Biologics Inc. HCWB · 2 buys · 0 sells 2 filings

Recent filings

HCWBPURCHASE HCW Biologics Inc. View filing → $160K
113,879 sh × $1.41
Exec May 22
Filed May 27 · 7:26 PM ET HCWBPURCHASE HCW Biologics Inc. View filing → $2.4M
92,500 sh × $26.00
Exec May 8 2025
Filed May 9 2025 · 5:30 PM ET